Deep integration of low-cost liquid handling robots in an industrial pharmaceutical development environment
Record generated from the current DIY biofabrication corpus.
- Year
- 2024
- Skill
- medium
- Docs
- limited
- Rubric
- 3.6 / 5
Implementation assessment
Scoring by criterion
Scores describe accessibility and implementation characteristics reported in the reviewed source. They are not a measure of scientific quality.
Resolution
Minimum volume evidence about 20 uL.
Scalability/Throughput
Evidence of parallel, plate-scale, multi-head, or unattended operation.
Build and Part Sourcing Complexity
Mix of common parts and custom/printed components.
Skill Complexity
Build/operation described as low-skill or basic assembly.
Equipment/Cosumable/Facility Requirement Accessibility
Uses common benchtop/desktop equipment or generic consumables.
Application Level
Presented as modular or usable across multiple workflows.
Accessibility to documentation
Some open documentation or files are available.
Validation/Troubleshooting Complexity
Validation includes standards, benchmarking, replicates, or multi-condition tests.
Speed/Cycle Time
Speed evidence suggests rapid, real-time, or automated operation.
Build Time
Build time not reported; assigned neutral score.
Record metadata
Publication data
Crossref and OpenAlex
Publication record
Abstract
The pharmaceutical industry is increasingly embracing laboratory automation to enhance experimental efficiency and operational resilience, particularly through the integration of automated liquid handlers (ALHs). This paper explores the integration of the low-cost Opentrons OT-2 liquid handling robot with F. Hoffmann-La Roche AG's in-house workflow orchestration software, AutoLab, to overcome barriers to lab automation. By leveraging the OT-2's development-oriented interfaces and AutoLab's modular architecture, we achieved a user-friendly, cost-efficient, and flexible automation solution that aligns with FAIR (findable, accessible, interoperable, reusable) data principles. We demonstrate an advanced workflow development methodology, utilizing the software architecture, that facilitates the creation of two flexible pipetting protocols and medium complexity assays. This deep integration approach diminishes the learning curve for novice users while simultaneously enhancing the overall efficiency and reliability of the experimental workflow. Our findings suggest that such integrations can significantly mitigate the challenges associated with lab automation, including cost, complexity, and adaptability, paving the way for more accessible and robust automated systems in pharmaceutical research.
Bibliographic details
Access and metrics
Topics and keywords
Perspective and practical signals
Why it matters
No narrative note curated yet.
Limitations
No limitation note curated yet.